6.1 Ordering, Acquisition & Distribution Records

Ordering, Acquisition & Distribution Records

Pharmacy operations begin with a disciplined supply chain. The PA MPJE tests whether you know where drugs may be sourced, what documentation must exist at receipt, how long records are kept, and what special rules apply to samples and outdated stock. Pennsylvania follows federal drug-chain rules but layers on 49 Pa. Code Chapter 27 recordkeeping requirements that are often stricter than sister states.

Sourcing from Licensed Wholesalers

A Pennsylvania pharmacy may purchase prescription drugs only from a wholesale distributor licensed by the PA State Board of Pharmacy and registered with the DEA. The pharmacist-in-charge (PIC) — called the pharmacist-manager in 49 Pa. Code §27.11 — is responsible for verifying each wholesaler's PA license and DEA registration before the first order and for keeping a current list of suppliers. Out-of-state wholesalers shipping into PA must also register with the PA Board; a pharmacy that buys from an unregistered out-of-state wholesaler is itself violating PA law.

For controlled substances, ordering follows federal CSA rules: Schedule II requires a DEA Form 222 (paper or Electronic Prescribing of Controlled Substances (EPCS)-style electronic order form) and a Form 222a requisition; Schedules III–V may be ordered on an ordinary invoice with the DEA registration number recorded. The PIC signs every CII order form and retains Copy 3 for 2 years.

Recordkeeping Under 49 Pa. Code §27.18

Section 27.18 of the Board's regulations governs pharmacy records. The rule requires that all drug acquisition records — invoices, packing slips, order forms, and receipts — be kept for at least 2 years from the date of transaction and be readily retrievable. For controlled-substance invoices, federal rules (21 CFR 1304.04 and 1304.11) similarly require 2 years, but the DEA may extend to 5 years by written notice; PA defaults to the 2-year minimum unless a longer federal demand is open. Records may be paper or electronic, but an electronic system must be capable of producing a printed, sortable audit trail on Board request.

DSCSA Product Tracing at Receipt

The Drug Supply Chain Security Act (DSCSA), with its final compliance date November 27, 2024, requires every pharmacy to receive three data elements for each package of a prescription drug at receipt:

• Transaction Information (TI) — product identifier (NDC), lot, expiration date, package size, number of packages.
• Transaction History (TH) — the chain of sale from manufacturer through distributor.
• Transaction Statement (TS) — a signed statement that the trading partner is authorized and the product is not suspect or illegitimate.

A pharmacy must not accept product when tracing information is missing or incomplete. If the pharmacy identifies suspect product (counterfeit, diverted, recalled), it must quarantine the product, investigate, and notify the FDA and trading partners within 24 hours of confirming illegitimate product. Authorized trading partners under DSCSA are manufacturers, repackagers, wholesale distributors, and dispensers (pharmacies). Exemptions: blood products, radioactive drugs, imaging drugs, OTC monograph products, and most compounded products.

Returning Outdated Stock

Outdated, expired, or recalled non-controlled stock must be returned to the licensed wholesaler with a return-goods authorization, or destroyed in a manner consistent with state and local hazardous-waste rules. The pharmacy documents the return on the invoice file and adjusts inventory. For controlled substances, return or destruction uses DEA Form 41 (Render Unfit for Use) or a reverse distributor authorized by DEA; the PIC signs and retains the Form 41 for 2 years. Expired controlled substances may not simply be thrown into the trash — that is diversion and a recordkeeping violation.

Drug Samples and the PDMA

The Prescription Drug Marketing Act (PDMA) of 1987 prohibits the sale, purchase, or trade of drug samples and prohibits a retail pharmacy from distributing samples at all. A sample is a drug marked "Caution: Federal law prohibits dispensing without prescription" or labeled as a sample, or provided free of charge by a manufacturer. Samples may be distributed only by a manufacturer or authorized distributor to a licensed practitioner (physician, hospital, HMO) for free distribution to patients; records of request, receipt, and storage are required (21 CFR 1304.31 area). A retail pharmacy may not accept samples from a sales representative and may not bill any third party for a sample product. Violations are misdemeanors under 21 USC §353(d) and carry pharmacy license sanctions.

Records & Retention Table

Exam Traps

• "May a PA pharmacy accept a free sample bottle from a drug rep?” — No. PDMA bars retail possession of samples entirely.
• “Are DSCSA tracing statements required for OTC famotidine?” — No; OTC monograph products are exempt.
• “How long is a CII invoice kept?” — 2 years under PA, unless the DEA has issued a written 5-year extension notice.
• “Who signs the DEA Form 222?” — The PIC (pharmacist-manager), not a technician.